Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2020

Planlagt Fastgjort Låst Flyttet Genmab
767 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #581

    turned nicely on the 2194 Thursday low, let's see if it can turn into a small double bottom

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Plimsoller
      wrote on sidst redigeret af
      #582

      Still doesn't work after closing the browser, but I will reboot after work. Thanks for your help 🙂

      1 Reply Last reply
      0
      • V Offline
        V Offline
        Vitus
        wrote on sidst redigeret af
        #583

        Er der ellers nogle holdninger til aktien 🙂

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #584

          På lang sigt skal aktien up up and away. Pga epco, GEN1046, Amivantamab, Kesimpta. Genmab går fra at være en one trick pony, til et multiblockbuster biotech selskab

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GeorgeBest
            wrote on sidst redigeret af
            #585

            Specielt epco og GEN1046 er ekstremt vigtige da Genmabs ejerandel er 50%

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #586

              GEN1046 could be the jackpot if it works as good as Jan thinks... but it will still take some time; i don't think the data in november will be able to show us the full potential yet

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #587

                Agree

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #588

                  I think Amivantamab is vastly underrated.... JNJ is throwing a lot of effort into it and i think it will be filed sooner as expected -> double royalties at no cost to genmab

                  1 Reply Last reply
                  0
                  • nohopeN Offline
                    nohopeN Offline
                    nohope
                    wrote on sidst redigeret af
                    #589

                    Estimated Primary Completion Date : April 30, 2024

                    1 Reply Last reply
                    0
                    • nohopeN Offline
                      nohopeN Offline
                      nohope
                      wrote on sidst redigeret af
                      #590

                      Estimated Study Completion Date : November 20, 2025

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #591

                        is that Mariposa? we will not have to wait for that. they have breakthrough therapy designation from the FDA

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #592

                          and...

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #593

                            Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/ct2/show/NCT04599712

                            1 Reply Last reply
                            0
                            • nohopeN Offline
                              nohopeN Offline
                              nohope
                              wrote on sidst redigeret af
                              #594

                              Ok. Great 🙂

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #595

                                It looks good EL - thanks.

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #596

                                  The Phase 1 Talquetamab trial changed into a Phase 1/Phase 2 and increases enrollment from 185 to 245 https://clinicaltrials.gov/ct2/history/NCT03399799?A=20&B=21&C=merged#StudyPageTop

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #597

                                    i hope that means the expansion phase is starting? maybe we can get some data at ASH ?

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #598

                                      Stoxx: Europæiske health care aktier i plus i stærk negativt
                                      markedhttps://www.proinvestor.com/investornyt/668982/stoxx-europaeiske-health-care-aktier-i-plus-i-staerk-negativt-marked

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #599

                                        Ses vi til øl i aften? https://event.webinarjam.com/register/5/qro52t7

                                        1 Reply Last reply
                                        0
                                        • M Offline
                                          M Offline
                                          Mogan
                                          wrote on sidst redigeret af
                                          #600

                                          Der er da gang i fukssvansen i dag, men nogen vil have kursen ned, uanset de små opture hen over dagen.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger